Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for FREE ACCESS to this landmark database

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chez, M. G.
Right arrow Articles by Komen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chez, M. G.
Right arrow Articles by Komen, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Double-Blind, Placebo-Controlled Study of L-Carnosine Supplementation in Children With Autistic Spectrum Disorders

Michael G. Chez, MD

Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL, mchezmd{at}interaccess.com

Cathleen P. Buchanan, PhD

Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL

Mary C. Aimonovitch

Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL

Marina Becker, RN

Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL

Karla Schaefer, RN

Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL

Carter Black, RPh

Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL

Jamie Komen, MA

Research Division, Autism and Epilepsy Specialty Services of Illinois, Ltd, Lake Bluff, IL

L-Carnosine, a dipeptide, can enhance frontal lobe function or be neuroprotective. It can also correlate with {gamma}-aminobutyric acid (GABA)-homocarnosine interaction, with possible anticonvulsive effects. We investigated 31 children with autistic spectrum disorders in an 8-week, double-blinded study to determine if 800 mg L-carnosine daily would result in observable changes versus placebo. Outcome measures were the Childhood Autism Rating Scale, the Gilliam Autism Rating Scale, the Expressive and Receptive One-Word Picture Vocabulary tests, and Clinical Global Impressions of Change. Children on placebo did not show statistically significant changes. After 8 weeks on L-carnosine, children showed statistically significant improvements on the Gilliam Autism Rating Scale (total score and the Behavior, Socialization, and Communication subscales) and the Receptive One-Word Picture Vocabulary test (all P < .05). Improved trends were noted on other outcome measures. Although the mechanism of action of L-carnosine is not well understood, it may enhance neurologic function, perhaps in the enterorhinal or temporal cortex. (J Child Neurol 2002;17:833—837).

Journal of Child Neurology, Vol. 17, No. 11, 833-837 (2002)
DOI: 10.1177/08830738020170111501


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?